The stock of Heart Test Laboratories Inc. (NASDAQ:HSCS) decreased by -$0.25 on Tuesday to finish at $0.44, down -36.60 percent. The last five days have seen an average of 408,680 shares of common stock traded. 5 times new highs were reached in the current year, with a fall of -$0.3999. The average number of shares traded over the last 20 days was 131,935, while the average volume over the last 50 days totaled 98,952.
HSCS stock dropped -38.89% since last month. On 09/19/23, the company’s shares reached a one-month low of $0.3001. The stock touched a high of $3.95 on 02/03/23, after rallying from a low of $0.60 in 52 weeks. The price of HSCS stock has declined by -47.61% or -$0.3999 this year, reaching a new high 5 times. Still, the stock price is down -88.86% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Financial Health
For the three months ended July 30, Heart Test Laboratories Inc.’s quick ratio was 0.70, while its current ratio was 1.10, indicating its inability to pay off its debt. The company’s long-term debt to equity ratio for the quarter ending July 30 is 1.00, and the total debt to equity ratio is 2.00. Based on annual data, it had gross profit of $2000.0 and revenue of $5000.0.
Earnings Surprise
According to Heart Test Laboratories Inc.’s quarterly financial report for the quarter that ended July 30. It was predicted that Heart Test Laboratories Inc.’s quarterly earnings would be -$0.13, but it ended up being -$0.14, beating the consensus by 7.10%. EBITDA was -$1.32 million for the quarter. At the end of Heart Test Laboratories Inc.’s most recent quarter ended July 30, its liabilities totaled 3.12 million, while its total debt was $1.58 million. Equity owned by shareholders amounts to $10.92 million.
Technical Picture
Here’s a quick look at Heart Test Laboratories Inc.’s (HSCS) price momentum from a technical perspective. As of 19 September, the RSI 9-day stood at 19.53%, suggesting the stock is oversold, with a 240.11% historical volatility rate.
The stochastic %K and %D were 46.11% and 68.27% respectively, while the average true range (ATR) was 0.1320. Based on the 14-day stochastic reading of 25.36%, the RSI (14) reading is 24.48%. On the 9-day MACD Oscillator, the stock is at -0.0909, and the 14-day reading is at -0.0820.
Analyst Ratings
Analysts have assigned Heart Test Laboratories Inc. (HSCS) an Buy rating. HSCS is a stock that is recommended for selling by 0 brokerage firms, while 0 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.
What is HSCS’s price target for the next 12 months?
The current consensus forecast for the stock is between $3.70 and $3.70, with a median target price of $3.70. In analyzing these forecasts, the average price target given by analysts for Heart Test Laboratories Inc. (HSCS) is $3.70.
